Global Cardiovascular Digital Solutions Market Segments 2024, Forecast To 2033
5 Mar, 2024
The cardiovascular digital solutions market has shown rapid growth, with its size rising from $91.02 billion in 2023 to $100.81 billion in 2024, marking a 10.8% CAGR. The growth is attributed to factors like the increase in cardiovascular diseases, telemedicine adoption, and data analytics for risk prediction. Moving into 2028, the market is expected to reach $147.86 billion, growing at a 10.1% CAGR, driven by AI and machine learning integration, the expanding role of digital biomarkers, and remote cardiac rehabilitation programs.
Global Cardiovascular Digital Solutions Market Key Driver
The cardiovascular digital solutions market is set to grow with the rise in cardiovascular disease prevalence worldwide. Cardiovascular diseases, projected to cause over 22.2 million deaths in 2030, highlight the urgent need for digital solutions. These solutions empower patients to self-monitor health activities, reducing risk factors and enhancing adherence to lifestyle changes, thereby mitigating the impact of cardiovascular diseases.
Get A Free Sample Of The Global Cardiovascular Digital Solutions Market ReportGlobal Cardiovascular Digital Solutions Market Segments
The cardiovascular digital solutions market covered in this report is segmented –
1) By Components: Devices, Software
2) By Services: Unobtrusive Testing, CVD Health Informatics, Cardiac Rehab Programs, Other Services
3) By Deployment: Cloud-Based, On-Premise
4) By End-Use: Hospitals and Clinics, Ambulatory Care Centers, Other End-Users
By Geography: The regions covered in the anti inflammatory therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe,North America, South America, Middle East, and Africa. Among these regions.
North America was the largest region in the cardiovascular digital solutions market in 2023. Asia-Pacific is expected to be the fastest-growing region in the cardiovascular digital solutions market report during the forecast period. The regions covered in the cardiovascular digital solutions market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Major Cardiovascular Digital Solutions Industry Players
iRythm Technologies Inc.; Apple Inc.; General Electric Company; Uber Diagnostics Private Limited; AlivCor Inc.; Verily Life Sciences; HeartFlow Inc.; Bardy Diagnostics Inc.; BioTelemetry Inc.; eviCore healthcare; Nanowear Inc; Cardiac Insight Inc.; Bay Labs Solutions; Change Healthcare; Medtronic PLC; BenevolentAI Limited; Cardiologs Technologies; Cardiopulmonary Corp.; Congenica Ltd.; Cyient Limited; Data4Cure Inc.; Deep Genomics Incorporated; DNAnexus Inc.; Emedgene Technologies Ltd.; Fabric Genomics Inc.; FDNA Inc.; Freenome Holdings Inc.; GNS Healthcare; IBM Watson Health; Illumina Inc.; Microsoft Corporation; Niramai Health Analytix; NVIDIA Corporation; Omron Healthcare Co. Ltd.
Get The Full Global Cardiovascular Digital Solutions Market Report
AIOps Cardiovascular Digital Solutions Market Overview
Cardiovascular digital solutions refer to the utilization of technological solutions with personalized approaches to cardiovascular diagnosis and treatment by using wearables, smartphones, software, sensors, and artificial intelligence. These are used to promote adherence to lifestyle changes and increase patient autonomy by enabling patients to self-monitor health interventions.
Cardiovascular Digital Solutions Global Market Report 2023 provides data on the global cardiovascular digital solutions market such as market size, growth forecasts, segments and geographies, competitive landscape including leading competitors’ revenues, profiles and market shares. The cardiovascular digital solutions market report identifies opportunities and strategies based on market trends and leading competitors’ approaches.